SEC Filings
Akebia's Chief Commercial Officer Resigns Effective November 6, Then Moves To A Paid Consulting Role
Nicholas Grund will advise Akebia through April 30, 2027 at an hourly rate, according to an 8-K filed Wednesday.
SEC Filings
Nicholas Grund will advise Akebia through April 30, 2027 at an hourly rate, according to an 8-K filed Wednesday.
SEC Filings
The license adds up to $47.5 million in milestones and mid-teens royalties, with launch targeted for April 2027 pending final FDA approval.
SEC Filings
The license adds a mid-teens royalty and a 20-year supply deal, and Eton anticipates an April 2027 launch, subject to final FDA approval.
SEC Filings
The 8-K says $185 million is due within 30 business days, with $145.4 million to follow in two installments.
SEC Filings
Frank Martell becomes lead independent director and Steven Sordello chairs the governance committee, the company said in an 8-K.
SEC Filings
The semiconductor materials supplier's board set the payout date and record date in an 8-K filed Wednesday.
SEC Filings
Xeris Biopharma's 8-K names seven defendants in two New Jersey federal cases and seeks an injunction plus damages.
SEC Filings
Liquidia keeps YUTREPIA on the market for PAH, drops its appeal and strips the PH-ILD use from the label.
SEC Filings
A Schedule 13D/A shows KKR's Independence Energy Aggregator bought in the offering and accepted a lock-up, with no new demands.
SEC Filings
Control Empresarial sold on the NYSE from October 8 to October 13 at average prices of $17.031 to $17.5101, an amended 13D shows.
SEC Filings
The fund holds the shares as KKR affiliates pursue a $127-per-share cash buyout of Integer, and a separate cash swap covers 836,392 more.
SEC Filings
An amended ownership filing says the Lubin group now holds 4.9% and has no current plans to change SharpLink's board or management.